Drug Markets/Fremanezumab-Vfrm

Fremanezumab-Vfrm

3 NDCs across 1 manufacturer|0 Generic,3 Brand

▸ More about this market

In 2024, Medicare Part D spent $103 million on Fremanezumab-Vfrm across 116,000 claims for 24,000 beneficiaries.

Fremanezumab-Vfrm is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $507.45 to $508.51 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

0G / 3B

Manufacturers

1

competing in market

Price Spread

$507.45 – $508.51

per ML

7d Activity

1↓0 flat

avg -0.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing FREMANEZUMAB-VFRM

Drug Portfolio

3 NDCs total, 3 shown

Drug ↕Price 7d Change ↕
AJOVY 225 MG/1.5 ML SYRINGE
$508.5072
per ML
-0.02%
AJOVY 225 MG/1.5 ML AUTOINJECT
$508.1707
per ML
0.00%
AJOVY 225 MG/1.5 ML AUTOINJECTOR (3 PACK)
$507.4470
per ML
0.00%

Frequently Asked Questions

How much does Medicare spend on Fremanezumab-Vfrm?

In 2024, Medicare Part D spent $103 million on Fremanezumab-Vfrm across 116,000 claims for 24,000 beneficiaries.

How many Fremanezumab-Vfrm products are on the market?

The Fremanezumab-Vfrm drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.

What is the price range for Fremanezumab-Vfrm?

NADAC reference prices for Fremanezumab-Vfrm range from $507.4470 to $508.5072 per ML — a 0% difference between cheapest and most expensive.

Which manufacturers make Fremanezumab-Vfrm?

1 manufacturer lists Fremanezumab-Vfrm in NADAC. Ranked by number of NDCs, the largest are Teva Pharmaceuticals USA Inc. (3).

How has the price of Fremanezumab-Vfrm changed recently?

Over the past 7 days, 0 Fremanezumab-Vfrm NDCs rose and 1 fell, with a market-wide average change of -0.0%.